Last
modified
June 4, 2009
 |
NEW!
BioProtein
Technologies creates BioProtein Transgenics
a subsidiary company specialized in the development and
production of transgenic rabbit animal models
-->
More...
|
|
PRESS
RELEASE
BioProtein
obtains licence form GTC Biotherapeutics
--> More...
|
|
|  ::
MANUFACTURING SERVICES ::
|
|
BioProtein
Technologies is a Contract Manufacturing
Organization specializing in the production
of human therapeutic proteins & vaccines
in the milk of transgenic rabbits.
BioProtein Technologies' unique manufacturing capabilities
are designed to provide pharmaceutical
and biotechnology companies, as well as academic
and research organizations, with the highest standard in
recombinant protein & vaccine production.
|
| RECOMBINANT
PROTEIN PRODUCTION |
RECOMBINANT
VACCINE PRODUCTION |
|
- Monoclonal Antibodies
- Plasma Proteins
- Hormones
- Peptides |
- Vaccines based on vaccinating proteins
- Multivalent VLP-based Vaccines
--> More…
|
|
The Company’s proprietary technology platform allows
it to provide customers with gram
to kilogram quantities of highly purified biopharmaceuticals
within competitive time-frame.
-->
More…
|
|
:: EXPERTISE ::
|
|
BioProtein
Technologies has privileged access to the expertise
and know-how developed by INRA (French Agronomy Research
Institute) for the production of recombinant proteins
and vaccines in the milk of transgenic rabbits.
--> More... |
|
:: CREATION OF BIOPROTEIN
TRANSGENICS:: |
|
BioProtein
Technologies creates BioProtein Transgenics, a subsidiary
company dedicated to the development and production
of transgenic rabbits to be used as animal models for
the study of human diseases.
-->
More...
|
|
|
